https://www.selleckchem.com/pr....oducts/gsk1070916.ht
Thus, phosphatidylserine supplementation may represent a simple way to activate a pre-conditioning mechanism and may be a promising novel strategy to reduce infarct size following AMI and to prevent myocardial injury during myocardial infarction or cardiac surgery. Due to the minimal adverse effects, further investigation in large animals or in human are soon possible to establish the exact role of phosphatidylserine in cardiac diseases.The cerebral metabolic rate of oxygen consumption (CMRO2) is a key metric to investigate the mecha
Aimer
Commentaire
Partagez
